Recruiting Psoriatic Arthritis Studies in Covina
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
An open label phase 3 study...
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) wo...
About Psoriatic Arthritis Clinical Trials in Covina
Psoriatic arthritis is a form of inflammatory arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling. It can affect any joint and varies in severity. Treatment includes NSAIDs, DMARDs, biologics, and JAK inhibitors.
There are currently 2 psoriatic arthritis clinical trials recruiting participants in Covina, CA. These studies are seeking a combined 1,250 participants. Research is being sponsored by Sun Pharmaceutical Industries Limited, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Psoriatic Arthritis Clinical Trials in Covina — FAQ
Are there psoriatic arthritis clinical trials in Covina?
Yes, there are 2 psoriatic arthritis clinical trials currently recruiting in Covina, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Covina?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Covina research site will contact you about next steps.
Are clinical trials in Covina free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Covina studies also compensate for your time and travel.
What psoriatic arthritis treatments are being tested?
The 2 active trials in Covina are testing new therapies including novel drugs, biologics, and treatment approaches for psoriatic arthritis.
Data updated March 2, 2026 from ClinicalTrials.gov